Aerovate Therapeutics Statistics
Total Valuation
AVTE has a market cap or net worth of $8.12 million. The enterprise value is $1.78 million.
Market Cap | 8.12M |
Enterprise Value | 1.78M |
Important Dates
The last earnings date was Monday, May 12, 2025, after market close.
Earnings Date | May 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
AVTE has 828,142 shares outstanding. The number of shares has increased by 8.55% in one year.
Current Share Class | 28.99M |
Shares Outstanding | 828,142 |
Shares Change (YoY) | +8.55% |
Shares Change (QoQ) | -0.87% |
Owned by Insiders (%) | 3.59% |
Owned by Institutions (%) | 1,616.16% |
Float | 11.96M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.04 |
P/TBV Ratio | 1.04 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 32.01, with a Debt / Equity ratio of 0.00.
Current Ratio | 32.01 |
Quick Ratio | 31.53 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -59.01% and return on invested capital (ROIC) is -39.94%.
Return on Equity (ROE) | -59.01% |
Return on Assets (ROA) | -36.18% |
Return on Invested Capital (ROIC) | -39.94% |
Return on Capital Employed (ROCE) | -71.04% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.63M |
Employee Count | 30 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, AVTE has paid $55,000 in taxes.
Income Tax | 55,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.71% in the last 52 weeks. The beta is 0.95, so AVTE's price volatility has been similar to the market average.
Beta (5Y) | 0.95 |
52-Week Price Change | -98.71% |
50-Day Moving Average | 88.53 |
200-Day Moving Average | 81.25 |
Relative Strength Index (RSI) | 58.34 |
Average Volume (20 Days) | 18,389 |
Short Selling Information
Short Interest | 4.59M |
Short Previous Month | 4.29M |
Short % of Shares Out | n/a |
Short % of Float | 38.39% |
Short Ratio (days to cover) | 26.71 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -53.37M |
Pretax Income | -82.13M |
Net Income | -48.96M |
EBITDA | -53.11M |
EBIT | -53.37M |
Earnings Per Share (EPS) | -$59.34 |
Balance Sheet
The company has $76.21 million in cash and $312,000 in debt, giving a net cash position of $75.90 million or $91.65 per share.
Cash & Cash Equivalents | 76.21M |
Total Debt | 312,000 |
Net Cash | 75.90M |
Net Cash Per Share | $91.65 |
Equity (Book Value) | 75.05M |
Book Value Per Share | 90.62 |
Working Capital | 74.96M |
Cash Flow
Operating Cash Flow | -49.90M |
Capital Expenditures | n/a |
Free Cash Flow | -71.20M |
FCF Per Share | -$85.97 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
AVTE does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -8.55% |
Shareholder Yield | -8.55% |
Earnings Yield | -63.03% |
FCF Yield | -91.65% |
Analyst Forecast
The average price target for AVTE is $11.75, which is 19.90% higher than the current price. The consensus rating is "Hold".
Price Target | $11.75 |
Price Target Difference | 19.90% |
Analyst Consensus | Hold |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |